Hospital Processes Reengineering of Intravenous Thrombolysis in Acute Ischemic Stroke in China "PROMISE"


Phase N/A Results N/A

Summary of Purpose

PROMISE is a prospective, nationwide, multicenter, longitudinal cohort study, focusing on hospital intravenous thrombolysis process reengineering for acute ischemic stroke (AIS). With a proposed "Reengineered Process Framework" for intravenous thrombolysis process by the PROMISE study steering committee, about 30 medical centers enters would be recruited nationwide, and each center would include consecutive AIS...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 February 2016.

1 Jul 2014 26 Oct 2014 1 Dec 2015 1 Dec 2015 1 Feb 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample


Not available